Ben Adams

AbbVie's immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as longtime rival Dupixent took the crown in September.

A new survey commissioned by Big Pharma Roche has found that half of those polled “have either limited or no awareness” of the connection between a common infection and cervical cancer.

Big Pharmas, medical device companies and healthcare groups have teamed up with the International Society on Thrombosis and Haemostasis (ISTH) for a new campaign aimed at boosting awareness about how to spot and treat blood clots.

Oct. 21, 2024 Learn how fire codes and rules are enforced at state and local levels

Leo Pharma is launching a new U.S. healthcare awareness campaign aimed at doctors to boost their understanding of a specific type of eczema.

The U.K. government and its drug regulator have issued a new warning aimed at the misuse of GLP-1 therapies by those who don't qualify for the meds but are instead using them for quick-fix weight loss.

To improve its programs for countering violent extremism (CVE), the Australian government must better understand the gendered characteristics of extremism. And it needs to apply that knowledge to enhance the existing practices of CVE professionals who work with radicalised men.

With the FDA approval of the first specific drug for Metabolic Associated Steatohepatitis (MASH) in March this year, Madrigal’s Rezdiffra is a pioneer in a market set for rapid change.

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October.

For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal.